LMNX News and Press, Luminex Corporation From 10/07/20

Luminex Corporation (LMNX) announces Q3 revenues of ~$106M (+35% y/y) vs. a consensus of $105M.Molecular Diagnostics revenue was up ~100% y/y to ~$60M, Licensed Technologies revenue decreased ~10% to ~$35M and Flow Cytometry revenue was up ~13% to $10M.The company to release results on Nov. 2...

ABT is securing more orders for millions of its rapid covid-19 testing kits. While the medical devices segment was hit hard with double-digit declines in organic growth, trends in procedure volume show a path to recovery. Relative to other players in the rapid testing space, ABT h...

Luminex (LMNX) receives ~$5.4M award from the Biomedical Advanced Research and Development Authority or BARDA to conduct product development work and complete filing for Luminex's expanded NxTAG Respiratory Pathogen Panel.This includes the SARS-CoV-2 virus for high-throughput C...

Luminex Receives BARDA Award to Support 510(k) Filing for NxTAG Respiratory Pathogen Panel That Includes SARS-CoV-2 High-throughput diagnostic test will include most up-to-date respiratory pathogen targets PR Newswire AUSTIN, Texas, Sept. 24, 2020 AUSTIN, Texas...

The U.S. Department of Health and Human Services' Biomedical Advanced Research and Development Authority ((BARDA)) has awarded $683,500 to Luminex (LMNX) to support the enhancement of its xMAP SARS-CoV-2 Multi-Antigen IgG Assay which detects antibodies to three antigens of the coronavirus.The...

Luminex Receives BARDA Award to Support Enhancement of COVID-19 Multiplex Antibody Test Project will expand utility of xMAP SARS-CoV-2 Multi-Antigen IgG Assay to better indicate whether individuals are protected against future infection PR Newswire AUSTIN, Texas, Sept. 2...

Investment Thesis Enzo Biochem, Inc. ( ENZ ) is a vertically integrated life sciences company focusing on developing unique diagnostic platform technologies. Specific to the outbreak of COVID-19, ENZ also provides both molecular and serology tests in New York, New Jersey, and Connecticut. ...

Several stocks of companies that make COVID-19 diagnostic tests were sinking on Thursday following big news from Abbott Laboratories (NYSE: ABT) on Wednesday evening. Abbott announced that it received FDA emergency use authorization (EUA) for a COVID-19 antibody test that costs $5 and provi...

Image source: The Motley Fool. Luminex Corp (DE)   (NASDAQ: LMNX) Q2 2020 Earnings Call Aug 4, 2020 , 5:00 p.m. ET Operator Continue reading

Luminex Corporation (LMNX) Q2 2020 Earnings Conference Call August 4, 2020 05:00 PM ET Company Participants Harriss Currie - Senior Vice President and Chief Financial Officer Nachum Shamir - President and Chief Executive Officer Conference Call Participants Andrew Brackmann -...